ArticleThe Lancet. Oncology2022
De-escalation of radiotherapy after primary chemotherapy in cT1-2N1 breast cancer (RAPCHEM; BOOG 2010-03): 5-year follow-up results of a Dutch, prospective, registry study.
Sabine R de Wild et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
45 papers cite it
this paperpooled itcites it